Evaluation of Phenotypic Variations in the Antibiotics Sensitivity of Escherichia Coli by Repeated Exposure by Andrianarivelo, Andry Maharo et al.
6
International Journal of Clinical & Biomedical Research







© Authors; 2020.  (CC BY-NC-SA 4.0) 
This is an Open Access article which permits unrestricted 
non-commercial use, provided the original work is properly cited. 
Evaluation of Phenotypic Variations in the 
Antibiotics Sensitivity of Escherichia Coli by 
Repeated Exposure
Andry M Andrianarivelo1*, Christian E Mahavy2, Marson Raherimandimby2, Tsiry Rasamiravaka2
1Microbiology Laboratory of the Joseph Ravoahangy Andrianavalona University Hospital Center (Faculty of medicine 
Antananarivo Madagascar) 
2Microbiology Laboratory of Fundamental and Applied Biochemistry (Faculty of Sciences Antananarivo 
Madagascar) 
Abstract 
Enterobacteriaceae, in particular Escherichia coli, are habitual residents of the gastrointestinal tract, capable of 
causing a large number of infections. The MIC varies according to the bacterial strains and the antibiotics used, 
hence the need to carry out antibiotic sensitivity tests. The objective of this study is to evaluate the behavior of 
Escherichia coli after repeated exposure to the same antibiotic to demonstrate a possible correlation between 
excessive intake of antibiotics and bacterial resistance. A prospective and descriptive study was carried out in the 
Microbiology Laboratory of Fundamental and Applied Biochemistry (Faculty of Sciences Antananarivo) during the 
month of November 2019. The strains studied were the reference strain Escherichia coli ATCC 25922 provided by the 
Laboratory and two clinical strains from the Microbiology Laboratory of the Joseph Ravoahangy Andrianavalona 
University Hospital Center Antananarivo. Repeated exposure to Tobramycin and Ofloxacin of these strains were 
performed. The results of our study showed that most E. coli is exposed to the antibiotic, the more it develops 
resistance. The evolution of E. coli’s sensitivity is different in the presence of Tobramycin with MICs up to 4 times 
the starting value while in the presence of Ofloxacin, the MIC increases to 125 times the initial value. This difference 
may be due to the different target of the antibiotic which causes the bacteria to develop variable mechanisms to 
escape it. 
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IntroductIon
Enterobacteriaceae, in particular Escherichia coli, are habitual residents of the gastrointestinal tract, capable of 
causing a large number of infections [1]. The 
discovery of antibiotics at the beginning of the 
twentieth century was a real revolution in the 
medical field [2]. These molecules are powerful 
weapons capable of eradicating infectious 
diseases of bacterial origin. However, excessive, 
and uncontrolled use of antibiotics is one of 
the first pathways to bacterial resistance [3, 4]. 
Antibiotic resistance has gradually developed. 
It results from the repeated administration of 
antibiotics in humans or animals which creates 
conditions, called “selection pressure” favoring the 
acquisition and dissemination of strains resistant 
to antibiotics [5]. Reducing the excessive use of 
antibiotics and respect adequate therapeutic 
doses are part of the basic recommendations to 
fight against the spread of resistant bacteria. 
Indeed, it is recommended that an antibiotic 
should be used at least in doses 4 times higher 
than the minimum inhibitory concentration (MIC) 
to ensure good therapeutic success [6]. 
The MIC varies according to the bacterial strains 
and the antibiotics used, hence the need to 
carry out antibiotic sensitivity tests, especially 
on newly isolated strains [7]. However, it is also 
important to verify the existence of a variation in 
the effectiveness of these antibiotics on bacterial 
strains previously exposed to these same 
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antibiotics at doses normally inhibiting their 
normal growth.
The objective of this study is to evaluate the 
behavior of Escherichia coli after repeated 
exposure to the same antibiotic to demonstrate 
a possible correlation between excessive intake of 
antibiotics and bacterial resistance.
MaterIal and Methodology
A prospective and descriptive study was 
carried out in the Microbiology Laboratory of 
Fundamental and Applied Biochemistry (Faculty 
of Sciences Antananarivo) during the month of 
November 2019. The strains studied were the 
reference strain Escherichia coli ATCC 25922 
provided by the Laboratory and two clinical 
strains from the Microbiology Laboratory of the 
Joseph Ravoahangy Andrianavalona University 
Hospital Center Antananarivo. Repeated 
exposure to Tobramycin and Ofloxacin of these 
strains were performed.
Escherichia coli strains were cultured in LB-
MOPS medium (Luria Bertani, supplemented 
with a buffer system of 3- (N-morpholino) 
propanesulfonic acid which will stabilize the pH). 
After weighing the LB and MOPS, the powders 
are dissolved in distilled water in order to have a 
homogeneous mixture. The pH of the medium is 
regulated before autoclaving with 0.2N HCl or 1N 
KOH up to 7.2. The solid culture medium used 
in this work was Columbia agar of concentration 
42.5 g.l-1.
The antibiotics tested were Ofloxacin and 
Tobramycin, supplied by the Laboratory of 
Microbiology of Fundamental and Applied 
Biochemistry (Faculty of Sciences Antananarivo). 
A stock solution of antibiotics is prepared to have 
a concentration of 6mg.ml-1 for Tobramycin and 
1.5mg.ml-1 for Ofloxacin. Then the antibiotics 
are diluted in DMSO (Dimethylsulfoxide). To 
have these concentrations, the following formula 
is adopted:
DMSO volume = net weight weighed / Final 
concentration
The research for the MIC was then carried out 
which is the lowest concentration of a range 
of dilutions of antibiotic of half in half, which 
involves an inhibition of any visible bacterial 
growth after 24 hours of culture at 37°C [8, 9]. 
This value characterizes the bacteriostatic effect 
of an antibiotic.
As principle, the dilution method is used both in 
liquid medium than in solid medium. It consists 
in mixing the bacterial strain and the culture 
medium with a decreasing concentration of 
reason 2 antibiotics. The manipulation is done 
in a series of test tubes (for the macrodilution 
method) and the microplate or wells (for the 
method in microdilution).
A strain preculture of E. coliof 18h was prepared 
by introducing 500μl of stock strain of E. coli 
in 5ml of LB-MOPS liquid medium (pH = 7.2). 
The whole is incubated with shaking at 37°C 
for 24 hours. After centrifugation (3200 g for 5 
min), the bacterial suspension was washed in 
5 ml of LB-MOPS. The inoculum was obtained 
by adjusting the optical density of the bacterial 
population to a value of 0.04 at the wavelength 
of 600nm using a spectrophotometer.
Microdilutions were performed on a 96-well 
plate. For the first four lines (A, B, C and D), 
we deposited 3μl of Ofloxacin and 297μl of 
bacterial suspension in the first wells. The final 
concentration of Ofloxacin is then reduced to 
one hundredth of its initial concentration, i.e. 
15 μg.ml-1. Then, we put 150μl of bacterial 
suspension in the last eleven wells. This 
manipulation has been done for more certainty 
in the results.
For the last four lines (E, F, G and H), we deposited 
3 μl of Tobramycin (TM) and 297 μl of bacterial 
suspension in the first wells. The concentration 
of Tobramycin in the first well is then reduced to 
one hundredth of its initial concentration, i.e. 60 
μg.ml-1. The rest of the operation is the same as 
that previously done for Ofloxacin.
A successive dilution is then carried out. Using a 
micropipette, we took 150μl of solution from the 
first well and pour it into the second well on the 
same line. Similarly, we took the same volume 
from the second well and transferred it to the 
third well. The same procedure was repeated until 
well number 11. The operation is stopped at the 
eleventh well so that the twelfth well can be used 
as a positive control of the manipulation. This 
successive dilution technique makes it possible 
to have a decreasing antibiotic concentration of 
reason 2. Finally, the plate is then incubated 
with shaking at 37° C for 24 hours. After 24 
hours of incubation, the MIC is determined by 
the minimum molar concentration where there 
is no visible growth, i.e. it is determined by the 
last well where there is no clouding medium 
observable with the naked eye. The presence 
of visible growth is determined by adding 40 μl 
of p-iodonitrotetrazolium chloride (INT) at 0.2 
mg.ml-1. The pink or red coloration on the culture 
medium indicates the presence of bacterial 
growth after 30 minutes of incubation at 37° C.
For repeated exposure, the bacterial strain must 
be exposed to this same antibiotic throughout 
the treatment. From the colonies of the spot 
corresponding to the well of the IJC, 3 bights of 
the strain of E. coli were seeded in LB-MOPS for 
a pre-culture of 18 hours at 37° C with stirring. 
After washing and centrifugation, the optical 
density is measured at 600nm and should have 
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a value of 0.04. A culture on a 96-well plate 
for the determination of a new MIC is then 
carried out according to the same procedure. 
After incubation, adding INT to 0.2mg.ml-1 
will confirm the presence of bacterial growth 
in the 96-well plate. These stages constitute a 
second cycle of exposure to an antibiotic. The 
operation is repeated until the fifth generation of 
the Escherichia coli strain exposed to the same 
antibiotic.
results 
Three strains of E. coli were studied by looking 
for their respective MICs with Tobramycin and 
Ofloxacin.
Sensitivity to Tobramycin: Table 1 shows the 
results for the MIC(pg.ml-1) of Tobramycin as a 
function of the generations of E. coli.
Table 1: distribution of the MIC of E. 










G1 7,5 9,375 4,6875
G2 7,5 75 9,375
G3 30 75 9,375
G4 30 75 9,375
G5 30 75 9,375
Table 1 shows the respective MIC values for 
tobramycin as a function of the generations of 
E. coli. The lowest MIC value was 7.5 pg.ml-1 
for the strain ATCC 25922, 9.375 for the strain 
E. coli 1 and 4.6875 for the strain E. coli 2 for 
the first generations of E. coli tested respectively 
with Tobramycin. The maximum bacteriostatic 
activity was 30 pg.ml-1 for the ATCC 25922 
strain (4 times the initial strain), 75 pg.ml-1 for 
the E. coli 1 strain (8 times the initial strain) and 
9.375 for the E. coli 2 strain (twice the initial 
strain). These results are observed since the 
third generation for the ATCC 25922 strain and 
for the 2nd generation for the 2 other strains 
which no longer varies until the fifth generation 
(Table 1).
Table 2: Distribution of the MIC of E. coli 







MIC E coli 
2
G1 0,12 0,9375 0,9375
G2 0,46 37,5 1,875
G3 15 37,5 1,875
G4 15 37,5 1,875
G5 15 37,5 1,875
Sensitivity to Ofloxacin: Table 2 shows the 
respective MIC values for Ofloxacin as a function 
of the generations of E. coli.
Table 2 shows the respective MIC values for 
Ofloxacin as a function of the generations of E. 
coli. The lowest MIC value was 0.12 pg.ml-1 for 
the strain ATCC 25922, 0.9375 pg.ml-1 for the 
strain E. coli 1 and 2 for the first generations 
of E. coli tested respectively with Ofloxacin. The 
maximum bacteriostatic activity was 15 pg.ml-1 
for the ATCC 25922 strain (125 times the initial 
strain), 37.5 pg.ml-1 for the E. coli 1 strain (40 
times the initial strain) and 1.875 for the E. coli 
2 strain (twice the initial strain). These results 
have been observed since the third generation 
for the ATCC 25922 strain and for the 2nd 
generation for the 2 other strains which no 
longer varies until the fifth generation (Table 2).
dIscussIon
To assess phenotypic variations in Escherichia 
coli susceptibility to antibiotics after repeated 
exposure under in vitro conditions, we investigated 
the minimum inhibitory concentration (MIC) of 
Tobramycin and Ofloxacin. The MIC identifies 
the sensitivities of bacterial strains when faced 
with an antibiotic. It also makes it possible to 
adapt the dosages by comparison of MICs and 
serum dosages [10].
The results of our study showed that most E. coli 
is exposed to the antibiotic, the more it develops 
resistance. The evolution of E. coli’s sensitivity 
is different in the presence of Tobramycin with 
MICs up to 4 times the starting value (Table 
1) while in the presence of Ofloxacin, the MIC 
increases to 125 times the initial value (Table 
2). This difference may be due to the different 
target of the antibiotic which causes the bacteria 
to develop variable mechanisms to escape it. E. 
coli’s strategies to escape the action of antibiotics 
are numerous such as target modifications, 
enzyme inactivation or the efflux pump system 
[11, 12].
Compared to data from CA-SFM (2019), E. coli is 
resistant to Tobramycin from the first generation 
for the three strains. However, it should be 
emphasized that the culture medium used for 
the determination of the MIC is not identical (LB-
MOPS medium versus Mueller-Hinton medium), 
which makes the comparison not very timely.
Regarding sensitivity to Tobramycin, studies 
by Brilt MR, Dhondikubeer andal. [13, 14] 
have shown that Tobramycin has antibacterial 
activity against Gram negative bacteria, in this 
case E. coli, and has an MIC value between 4 
and 8 pg.ml-1.
Based on the results of our study, we found that 
E. coli has a basic sensitivity to Tobramycin at 
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a concentration of 7.5 pg.ml-1 for ATCC 25922, 
9.375 for E. coli 1 and and 4.6875 for E. coli 2 
for the first exposure to antibiotic which evolves 
towards resistance from the 3rd generation for the 
ATCC 25922 strain and from the 2nd generation 
for the E. coli 1 and 2 strain. This modification 
of the MIC is probably linked to a selection of E. 
coli resistant preexisting or the appearance of an 
inducible resistance. Development of resistance 
to Tobramycin de novo seems unlikely since the 
MIC stabilizes in the 5th generation.
This resistance to Tobramycin is due to several 
mechanisms, the most frequent of which 
is the result of the production of enzymes 
which covalently modify the antibiotics which 
then become inactive either by acetylation, 
phosphorylation or by nucleotidylation [15]. 
Studies by Menard andal. [16] showed that 
the strains of E. coli studied in their work are 
resistant to Tobramycin at MIC values of 8 
pg.ml-1 and that the overproduction of the 
enzyme [APH (3’)] - gives E. coli resistance to 
Tobramycin. Inactivation enzymes AAC (3) -IIa 
and AAC (6’) - Ib are also potential resistance 
agents for E. coli against Tobramycin [17].
Other resistance mechanisms may also be 
involved, such as target alteration (16S RNA), 
impermeability or active efflux of the antibiotic 
[18, 19]. The methylation of the nucleotide 
G1405 in position N7 in the 16S rRNA generates 
a mechanism of resistance to Tobramycin in E. 
coli described by Rosenberg andal. [20].
E. coli active efflux pumps against Tobramycin 
are numerous but AcrD-TolC is undoubtedly the 
most used to expel antibiotics out of the cell [20, 
21, 22].
Concerning the sensitivity to Ofloxacin, the value 
of the initial MIC of the first generation ATCC 
25922 strain of E. coli tested with Ofloxacin in 
our study is 0.12 pg.ml-1 (Table 2). These values 
conform to the reference set up by the CA-SFM 
[7]. In addition, these results corroborate the 
results of studies by Neu andal. [23] who shows 
that Ofloxacin has an antibacterial effect and 
who found an MIC value of 0.12 pg.ml-1. For 
the other 2 strains, they are very resistant to 
Ofloxacin because we found a minimum MIC of 
0.9375 pg.ml-1 for the 2 strains of E. coli for the 
first generations which will become even more 
resistant to the 5th generation (Table 2).
Thus, the results obtained in this study show that 
in the first generation of the strain ATCC 25922 
from E. coli, the strain is sensitive. Then, an 
intermediate phenotype characterizes the second 
generation. The first sign of resistance occurs in 
the third generation, i.e. the third exposure of E. 
coli to Ofloxacin with an MIC of 15 pg.ml-1. From 
the third generation, the strain became resistant 
to Ofloxacin. The difference between the value of 
the first generation MIC (0.12 pg.ml-1) and the 
third generation MIC (15 pg.ml-1) would mean 
that resistance mechanisms have been activated 
by E. coli to escape the action of Ofloxacin or that 
preexisting resistant populations were selected 
as is the case for the 2 other strains of E. coli 
that have already been resistant to Oflocaxine.
However, it should be noted that by their 
mechanism of action, fluoroquinolones are very 
mutagenic. Thus, these results could also be due 
to the fact that E. coli has developed resistance 
acquired through repeated exposure. The main 
cause of this resistance is due to mutations in 
the determining regions (GyrA, GyrB) and to the 
prevalence of plasmid mediated resistance genes 
in E. coli [24, 25, 26]. Other mechanisms such 
as overexpression of efflux pumps and alteration 
of permeability are also possible.
The protection of topoisomerase by Qnr proteins 
would give E. coli resistance to Ofloxacin which 
can increase the MIC value by 10 to 100 times 
[27]. Another resistance mechanism involves a 
mutation in the modifying enzyme AAC (6’) - Ib-
cr which is capable of modifying the structure of 
Ofloxacin [28]. It describes that the enzymatic 
modification by AAC (6’) - Ib-cr is the most 
widespread resistance mechanism in E. coli. 
This mechanism can increase the MIC from 2 to 
4 times its initial value [29].
A mutation in the gene encoding DNA Gyrase-A 
(ATP-dependent) causes a high level of bacterial 
resistance by enzymatic inactivation and reduces 
the accumulation of Ofloxacin in E. coli [23, 30]. 
The expression of efflux pumps is one of the 
resistance mechanisms of E. coli. AcrAB-TolC is 
an E. coli efflux system which may decrease the 
susceptibility of Ofloxacin [31]. QepA, a proton-
dependent transporter, is a new efflux system 
that can increase the MIC value from 2 to 64 
times its original value [22, 28, 29].
Determining the biochemical and molecular 
mechanisms of antibiotic resistance in E. 
coli should be undertaken to confirm likely 
resistance phenotypes.
conclusIon 
This work has demonstrated that E. coli reacts 
differently to antibiotics by developing complex 
resistance mechanisms after they are exposed to 
the same antibiotic. In a bacterial population, 
the development of resistance to an antibiotic is 
the result of stressors linked to the presence of 
the antibiotic. The increase in the value of the 
MIC is a direct interpretation of this resistance. 
The value of the MIC of E. coli to Tobramycin and 
ofloxacin is highly variable for the initial MIC up 
to the 5th generation after repeated exposure. 
This significant increase in MIC reflects the 
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resistance of the strain which is generally due to 
the production of an enzyme which inactivates 
antibiotics or by overexpression of efflux pumps 
or by protection of the target of the antibiotic. 
We have thus found that the dose prescribed 
for taking an antibiotic (value 4 times the 
MIC) has been greatly exceeded if the bacteria 
is repeatedly exposed to the same antibiotic. 
A control of the consumption of antibiotics is 
strongly recommended as well as compliance 
with the necessary dose required for taking the 
antibiotic.
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